δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling.
Pain relief is the principal action of opioids. Somatostatin (SST), a growth hormone inhibitory peptide is also known to alleviate pain even in cases when opioids fail. Recent studies have shown that mice are prone to sustained pain and devoid of analgesic effect in the absence of somatostatin recep...
Main Authors: | Rishi K Somvanshi, Ujendra Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3885706?pdf=render |
Similar Items
-
Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors
by: Rishi K. Somvanshi, et al.
Published: (2012-04-01) -
Somatostatin-Mediated Regulation of Retinoic Acid-Induced Differentiation of SH-SY5Y Cells: Neurotransmitters Phenotype Characterization
by: Sneha Singh, et al.
Published: (2022-02-01) -
Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D<sub>2</sub> Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
by: Lakshmi Vasudevan, et al.
Published: (2019-08-01) -
Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway
by: Kanako Miyano, et al.
Published: (2021-10-01) -
Somatostatin Ameliorates β-Amyloid-Induced Cytotoxicity via the Regulation of CRMP2 Phosphorylation and Calcium Homeostasis in SH-SY5Y Cells
by: Seungil Paik, et al.
Published: (2021-01-01)